Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
25 Results for "
GSK3B
" in MedChemExpress (MCE) Product Catalog:
Products (25)
25 Results for "GSK3B" in MCE Product Catalog:
2
1
1 Cited Publications
Cat. No.: HY-N0657
CAS No.: 63902-38-5
1
1 Cited Publications
Target:
Research Areas:
GSK-3b Inhibitor XI (Compound 33) is a potent and selective GSK3β inhibitor, with a Ki value of 25 nM. GSK-3b Inhibitor XI increases glycogen synthase (GS) activity. GSK-3b Inhibitor XI can be used for research on type 2 diabetes and Alzheimer’s disease .
1
Cat. No.: HY-RS05865
Target:
Research Areas:
GSK3B Human Pre-designed siRNA Set A contains three designed siRNAs for GSK3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS23620
Target:
Research Areas:
Gsk3b Rat Pre-designed siRNA Set A contains three designed siRNAs for Gsk3b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS17170
Target:
Research Areas:
Gsk3b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gsk3b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-183955
CAS No.: 2041071-54-7
Research Areas:
GNF7156 is a DYRK1A/GSK3B inhibitor, IC50 values of 100 nM for DYRK1A and 40 nM for GSK3B. GNF7156 inhibits DYRK1A and GSK3B kinase activity and induces NFAT nuclear retention. GNF7156 stimulates beta-cell cycle entry and division and maintains insulin secretory capacity. GNF7156 can be used for the research of type 1 diabetes, and type 2 diabetes [3].
Cat. No.: HY-N0657R
CAS No.: 63902-38-5
Cat. No.: HY-P702734
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: GSK3B; glycogen synthase kinase 3 beta; glycogen synthase kinase-3 beta; GSK-3 beta; GSK3Beta isoform; serine/threonine-protein kinase GSK3B
Species:
Source:
Cat. No.: HY-P73090
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Glycogen synthase kinase-3 beta; GSK-3 beta; GSK3B
Species:
Source:
Cat. No.: HY-P74114
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Glycogen synthase kinase-3 beta; GSK-3 beta; GSK3B
Species:
Source:
Cat. No.: HY-184447
CAS No.: 3091508-49-2
RN193 is a type II kinase inhibitor with a human PAK1 IC50 of 4.28 μM. RN193 functionally inhibits kinase activity of PAK1, PAK2, and PAK3, and engages with their kinase domains in live cells. RN193 induces thermal shifts in CLK1, GSK3B, ULK1, MELK, MAPK13, BRAF, and STK10, indicating binding and stabilization of these proteins. RN193 induces formation of PAK3:PAK2 heterodimers and displaces PAK2 homodimers in live cells. RN193 acts as a tool compound for studying group I PAK conformational states .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
